瑞士EffRx Pharmaceuticals
EffRx Pharmaceuticals SA是一家从事药物释放的公司，总部位于瑞士Freienbach。该公司利用其不同的泡腾实施创新技术，专长于改进现有的高容量药物产品。EffRx的主要工作重心放在代谢性骨病、肿瘤支持治疗、儿童用药领域，并为大型生命周期管理（Life Cycle Management）公司提供支持。

EffRx已与Takeda旗下的奈科明公司（Nycomed）达成授权协议，在除美国、加拿大和日本之外的全球范围开发、制造和商业化EffRx用于治疗骨质疏松的专利泡腾阿仑膦酸钠。

EffRx Pharmaceuticals SA is a drug delivery company based in Freienbach, Switzerland. EffRx specializes in improving existing high volume pharmaceutical products by utilizing its novel techniques in different effervescent executions. The primary focus of EffRx is in metabolic bone disease, oncology supportive care, pediatric medications and support to larger companies in Life Cycle Management.
EffRx has a licensing agreement with Nycomed, a Takeda Company, for development, manufacturing and commercialization of EffRx patented effervescent alendronate for the treatment of osteoporosis in all territories in the world except USA, Canada and Japan.